EMEA sets out 2015 road map for science, medicine and health

Science|Business reporting

The European Medicines Agency (EMEA) has set out its road map to 2015, outlining the contribution it aims to make to science, medicines, and health. The draft document is now open for public consultation.

The draft is intended to build on the strategy set out in 2005, which focused on contributing to better promotion and protection of public health, improving the regulatory environment, and helping to stimulate innovation, research and development in the EU.

The new document focuses on a number of issues that are relevant to academics, clinicians and companies involved in R&D. For example, the Agency says...

This page requires a subscription

This page is available to subscribers only. Please log in or subscribe and plug into the Science|Buisiness Network now, to get full access to all our news, events, business opportunities and subscriber-posting service.

We are the first independent news service connecting buyers and sellers of emerging technologies, across borders and across industries. We keep you ahead of the news on early-stage R&D investment – and provide opportunities for you to find and meet new investors, licensees and development partners, through our unique Science|Business Network of leading scientific institutions including the University of Cambridge, Karolinska Institute, ETH-Zürich and Imperial College London.

Be first into the next wave of technology. Click here to learn more

Note: Log in requires cookies to be enabled on your machine.

Lost your password? Enter your email address with no password and we'll send you a new password. Use this to log in, then, if you wish, click on the 'My Details' link at the top of the page to change your password.